Bridging from emergency contraceptive pills (ECPs) to regular contraception

ISRCTN	ISRCTN27688945
DOI	https://doi.org/10.1186/ISRCTN27688945
Secondary identifying numbers	Protection of Human Subject Committee, study #9978

Submission date: 19/03/2009
Registration date: 30/03/2009
Last edited: 30/03/2009

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Pregnancy and Childbirth

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Maxine Wedderburn
Scientific

25 Burlington Ave
Kingston
Kingston 10
Jamaica

Phone	+1 876 968 4976
Email	Maxwed@cwjamaica.com

Study information

Study design	Multicentre participant-randomised unblinded trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Other
Study type	Prevention
Scientific title	Building bridges from emergency contraceptive to regular contraceptive use in pharmacies: a multicentre participant-randomised unblinded trial
Study objectives	Can non-users of a regular contraceptive method (a regular contraceptive method for the purposes of this study is defined as either an oral contraceptive pill, an injectable contraceptive method or an intra-uterine devide [IUD]) in Jamaica who intended to purchase an emergency contraceptive product in a pharmacy be encouraged to move toward adopting regular contraception by providing a discount coupon for one cycle of a regular oral contraceptive pill product?
Ethics approval(s)	Family Health International Protection of Human Subjects Committee gave approval on the 28th November 2006 (ref: 9978)
Health condition(s) or problem(s) studied	Family planning
Intervention	The intervention is a discount coupon given to randomly designated clients who arrive at a pharmacy to purchase an emergency contraceptive product.
Intervention type	Other
Primary outcome measure	Adoption of a regular contraceptive method. Adoption is defined as: 1. Use of oral contraceptive pills for at least two months 2. Receiving one injection of an injectable contraceptive method and either having received a second injection or intending to receive a second injection 3. Use of an IUD for at least one month Measured at three and six months after participant enrolment (i.e., the pharmacy intercept interview).
Secondary outcome measures	Longest length of continuous use by women who adopt a regular contraceptive method. Measured at three and six months after participant enrolment (i.e., the pharmacy intercept interview).
Overall study start date	01/12/2006
Completion date	01/02/2008

Eligibility

Participant type(s)	Patient
Age group	Adult
Sex	Female
Target number of participants	800
Key inclusion criteria	Any woman (aged 16 - 46 years) who arrives at study pharmacy intending to purchase a dedicated emergency contraceptive product.
Key exclusion criteria	1. Males 2. Women under the age of 16 3. Women currently using a regular contraceptive method (a regular contraceptive method for the purposes of this study is defined as either an oral contraceptive pill, an injectable contraceptive method or an IUD)
Date of first enrolment	01/12/2006
Date of final enrolment	01/02/2008

Locations

Countries of recruitment

Jamaica

Study participating centre

25 Burlington Ave

Kingston
Kingston 10
Jamaica

Sponsor information

The William and Flora Hewlett Foundation (USA)
Charity

2121 Sand Hill Road
Menlo Park, CA
94025
United States of America

Email	info@hewlett.org
Website	http://www.hewlett.org/Default.htm
"ROR"	https://ror.org/04hd1y677

Funders

Funder type

Charity

The William and Flora Hewlett Foundation (USA)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan